Trump vs. Bannon and Romney Getting Back in the Political Ring
After news around Michael Wolff's book, "Fire and Fury: Inside the Trump White House," broke, the relationship between former White House advisor Steve Bannon and President Donald Trump completely deteriorated. The former team engaged in a very public fallout, but political consultant Rick Wilson was not all surprised. Wilson joins Cheddar to break down what this means for the GOP and how a Mitt Romney Senate run could further shake the White House.
Wilson explains that the Bannon and Trump fallout was inevitable because of their egos. Bannon's brand now could be hurt because of Trump's attack.
Wilson says the reports from the book are not revelations. Wilson explains how reporters have been hearing these stories and reporting on them for some time.
Wilson switches gears to address the news that Romney could run for Senator Orrin Hatch's seat in Utah. Wilson thinks Romney would have a good chance of winning. He also notes how Romney would play the opposite role to Trump in Washington.
Manhattan District Attorney Alvin Bragg filed a federal lawsuit against Rep. Jim Jordan on Tuesday, accusing the Republican of a “transparent campaign to intimidate and attack” him over his prosecution of former President Donald Trump.
Nashville’s governing council voted Monday to send Justin Jones straight back to the Legislature four days after he was expelled for his role in a protest on the state House floor.
The Justice Department is calling a Texas court ruling that would halt approval of the most commonly used method of abortion in the U.S. "extraordinary and unprecedented."
Nashville city councilors will likely appoint Justin Jones to his former seat on Monday while Memphis-area county commissioners will soon announce when they'll meet to fill the vacancy left by the expulsion of Justin Pearson, which Pearson himself is eligible to fill.
Health and Human Services Secretary Xavier Becerra said "Everything is on the table" when asked if he'd recommend that the FDA ignore Friday's ruling to reverse the agency's nearly 23-year-old approval of the medication abortion drug mifepristone.
